Kang, S.; Kim, Y.; Ahn, J.Y.; Jung, H.-Y.; Kim, N.; Na, H.K.; Lee, J.H.; Jung, K.W.; Kim, D.H.; Choi, K.D.;
et al. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics 2021, 10, 214.
https://doi.org/10.3390/antibiotics10020214
AMA Style
Kang S, Kim Y, Ahn JY, Jung H-Y, Kim N, Na HK, Lee JH, Jung KW, Kim DH, Choi KD,
et al. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics. 2021; 10(2):214.
https://doi.org/10.3390/antibiotics10020214
Chicago/Turabian Style
Kang, Seokin, Yuri Kim, Ji Yong Ahn, Hwoon-Yong Jung, Nayoung Kim, Hee Kyong Na, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi,
and et al. 2021. "Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting" Antibiotics 10, no. 2: 214.
https://doi.org/10.3390/antibiotics10020214
APA Style
Kang, S., Kim, Y., Ahn, J. Y., Jung, H.-Y., Kim, N., Na, H. K., Lee, J. H., Jung, K. W., Kim, D. H., Choi, K. D., Song, H. J., & Lee, G. H.
(2021). Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics, 10(2), 214.
https://doi.org/10.3390/antibiotics10020214
